Spike Protein News and Research

RSS
SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

Antibody responses following SARS-CoV-2 infection more potent than vaccine-elicited ones

Antibody responses following SARS-CoV-2 infection more potent than vaccine-elicited ones

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

SARS-CoV-2 interacts with sialic acid cell surface glycans

SARS-CoV-2 interacts with sialic acid cell surface glycans

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Mass spectrometry used to develop N-glycosylation profiles for SARS-CoV-2 D614G

Mass spectrometry used to develop N-glycosylation profiles for SARS-CoV-2 D614G

Mini-antibodies efficiently block SARS-CoV-2 virus

Mini-antibodies efficiently block SARS-CoV-2 virus

Unraveling the mysterious mutations that make delta the most transmissible covid virus yet

Unraveling the mysterious mutations that make delta the most transmissible covid virus yet

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

SARS-CoV-2 spike-specific antibodies induced in breast milk by COVID-19 vaccines

SARS-CoV-2 spike-specific antibodies induced in breast milk by COVID-19 vaccines

Study suggests mRNA SARS-CoV-2 vaccines remain effective against variants

Study suggests mRNA SARS-CoV-2 vaccines remain effective against variants

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

Variations in human ACE2 genetics associated with coronavirus susceptibility

Variations in human ACE2 genetics associated with coronavirus susceptibility